Follicular Lymphoma International Prognostic Index (FLIPI)

The Follicular Lymphoma International Prognostic Index (FLIPI) is a tool doctors use to predict how a patient with follicular lymphoma might respond to treatment and how the disease might progress. It considers five factors: age, tumor stage, hemoglobin level, number of affected lymph nodes, and lactate dehydrogenase (LDH) levels. Based on these, patients are grouped into risk categories (low, intermediate, high), helping physicians customize treatment plans and discuss prognosis more effectively. FLIPI helps provide a clearer picture of the disease course based on individual patient characteristics.